Acquisition - October 1, 2013
Clavis Pharma has signed a letter of intent to acquire Aqualis Offshore
Clavis Pharma has signed letter of intent to acquire Aqualis Offshore Ltd and proposes fully underwritten NOK 54 million rights issue. Clavis Pharma announces that following an evaluation of various strategic options after the negative outcome of the CLAVELA Phase III trial, Clavis Pharma (“Clavis” or the “Company”) has decided to enter the specialist marine […]
Acquisition - September 2, 2013
Meda acquires US respiratory company
Swedish Meda has signed an agreement to acquire the US development company Acton Pharmaceuticals, Inc. The agreement also includes the proprietary product Aerospan, an inhaler for the treatment of asthma that contains the active substance Flunisolide and approved by the FDA. The launch of Aerospan is planned to the beginning of 2014. According to Meda, the total […]
Acquisition - August 27, 2013
Chiesi buys Zymenex Holding A/S
Italian pharmaceutical company Chiesi Group has signed, through its UK affiliate, Chiesi Ltd., a definitive agreement with Sunstone Capital to acquire Zymenex Holding A/S and its related group of companies. Danish Zymenex is a biopharmaceutical group focused on research and development of innovative biologic therapeutics for the treatment of rare and life threatening genetic diseases. […]
Acquisition - August 26, 2013
MedImmune buys Amplimmune
The AstraZeneca unit MedImmune acquires US biotech company for up to $500 million. Amplimmune is based in Maryland and focuses on developing novel therapeutics in cancer immunology. According to AstraZeneca, the acquisition will bolster MedImmune’s oncology pipeline by obtaining multiple early-stage assets for its immune-mediated cancer therapy (IMT-C) portfolio, including AMP-514, an anti-programmed cell death 1 (PD-1) monoclonal […]
Acquisition - August 22, 2013
L2S firm collaborates with Pfizer
L2S AB, a life science company specialized in interactive cognitive behavioural therapy, has signed an international agreement with Pfizer. L2S, Learning 2 Sleep AB, is a Minc company based in Malmö with three part-owners. The company was founded in 2010 and provides services based on CBT treatment of sleeping disorders. One of the first services from […]
Acquisition - August 7, 2013
Probi expands in Asia
Swedish Probi and healthcare company BIO-LIFE have signed a partnership agreement for the launch of a probiotic product in Asia. PROBI and BiO-LiFE have signed a long term agreement to partner for the branding and launch of Probi’s Lactobacillus plantarum 299v. BiO-LiFE, a growing healthcare subsidiary within DKSH, will according to the agreement provide co-branding, […]
